VIA Disc NP Registry 3.0

Vivex Biomedical

Status: Enrolling

Conditions: Back Pain; Back Pain, Low; Discogenic Pain

Treatments: Other: VIA Disc NP

Study type: Observational

Funder types: Industry; Other

Identifiers

NCT06345690

VIA-2023-003

Details and patient eligibility

About

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Full description

The Registry is intended to collect data for patients having received treatment with VIA Disc NP.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Willing to sign the informed consent and deemed capable of complying with the requirements of the study protocol
2. 18 years of age or older
3. Literate, able to speak and read English, and able to complete questionnaires independently
4. Subject received a VIA Disc NP injection with 1 or more levels within 90 days of the baseline visit.

Exclusion criteria

1. Participant did not receive VIA Disc NP injection
2. Participant is pregnant (self-reported, no special study pregnancy testing needed).
3. Any contraindications as noted in the VIA Disc NP Instructions for Use
4. Previous treatment with VIA Disc NP

Trial design

500 participants in 1 patient group

VIA Disc NP

Description:

Patients meeting study criteria receiving Vivex VIA Disc NP injection as treatment

Treatment:

Other: VIA Disc NP